National Taiwan University Hospital
I am Yung-Ting Cheng from National Taiwan University Hospital. As a urologist, I primarily focused on the research of prostate cancer, especially the PHI study. Novel biomarkers had emerged to address such clinical limitations in the discrepancies between clinical cancer staging and pathological staging. We believed that our work would be very much of interest to the urologists, and helpful to those in the field of oncology.